American Journal of MedicineKoff RS.Cost-effectiveness of treatment for chronic hepatitis C. Journal of Hepatology . 1999Wong JB. Cost-effectiveness of treatments for chronic hepa- titis C. Am J Med 1999;107(6B):74S- 8S.Koff RS. Cost-effectiveness of treatment for chronic hepatitis C. J ...
including the phase 3 data on sofosbuvir plus ledipasvir as a single pill used as an 8-week successful treatment with a 95% cure rate.[1]Also in theNew England Journal of Medicinewas a publication on a different interferon-free approach and one we've seen before. This was in cirrhotic ...
In the United States (US), hepatitis C virus (HCV) screening is not covered by payers in settings outside of primary care. A non-traditional, emergency department (ED)-based HCV screening program can be cost-effective and identify infection in vulnerable populations with a high HCV risk. Thi...
Citation:SUN Xin,YANG Huan,WANG Li,Ewa Orlewska,Li Youping. Cost-effectiveness of Treatment of Chronic Hepatitis B in China: A Systematic Review. Chinese Journal of Evidence-Based Medicine, 2005, 05(11): 833-845. doi:Copy Copyright © the editorial department of Chinese Journal of Evidence...
Cost-effectiveness of treatments for chronic hepatitis C Consequently, numerous pharmacoeconomic studies have sought to estimate the marginal cost-effectiveness of initial interferon treatment for chronic hepatitis C. ... John,B,Wong - 《American Journal of Medicine》 被引量: 106发表: 1999年 ...
- 《Annals of Internal Medicine》 被引量: 611发表: 2012年 Cost effectiveness of combination therapy for hepatitis C: a decision analytic model OBJECTIVE: To estimate the cost utility of treatment with combination therapy (ribavirin and interferon alpha) for hepatitis C compared with no treatment o...
Researchers, led by Sammy Saab of the David Geffen School of Medicine at UCLA, sought to determine if HCV treatment would be cost-effective in the male prison population (men make up over 87 percent of U.S. prisoners). They examined published literature for relevant studies and constructed a...
A study led by Boston Medical Center (BMC) researchers demonstrates that while new therapies to treat Hepatitis C Virus (HCV) are highly effective, they are cost-effective and provide the greatest value in specific groups of HCV-infected patients. The findings of the study, led by Benjamin P....
Bennett,G William - 《Annals of Internal Medicine》 被引量: 1406发表: 1997年 New protease inhibitors for the treatment of chronic hepatitis C: a cost-effectiveness analysis. Chronic hepatitis C virus is difficult to treat and affects approximately 3 million Americans. Protease inhibitors increase th...
Electron micrographs of hepatitis C virus purified from cell culture. Scale bar is 50 nanometers. Credit: Center for the Study of Hepatitis C, The Rockefeller University. The cost of treating hepatitis C virus (HCV) could be cut up to 50 percent if mathematical models are used to predict wh...